Bridging the gap between R&D Project and clinical Development
Our Offer at a glance
From Regenerative Medicine to Immuno-Oncology,
From Autologous strategy to Allogeneic approach,
From primary cells to GMO cells
From Manufacturing Process, Analytics Bioassays, Quality Control Testing to Stability studies,
YOUR REQUIREMENTS ARE OUR PRIORITIES
YOUR Development stages
iPS Cells
Adult Stem Cells
EV & Exoxomes
Engineered Cells (CAR-T, CAR-NK,…)
Other ATMPs
Discovery
Pre-Clinical Development
Clinical Development
NDA Review
& Approval
- Ph.I
- Ph.II
- Ph.III
Post-Market monitoring
- Ph.IV
OUR Offer
Regulatory coaching
Supply chain & human tissues sourcing
Process & analytical development
Process & analytical validation
Technical Transfer
R&D manufacturing
cGMP manufacturing
QC release & stability studies
Our partners
THEY TRUST US !
News
Press
28.02.2022
The OPTI-STEM consortium led by Cell-Easy to democratize access to cell therapy in France and Europe
Toulouse, La Madeleine, Nancy, France – 28 February, 2022 The […]
Press
07.02.2022
Virginie Duel joins Cell-Easy as Head of Quality Control.
The Cell-Easy management team is very pleased to announce the […]
Contact
- Tel : +33 534 276 550
- Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
- Mail : info@cell-easy.com
European leading CDMO company specialized in large volume industrialized production of GMP approved cell products